Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 22:07 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableUnknownINTERVENTIONAL

Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity

ClinicalTrials.gov · NCT01595334 · Registry updated: 2012-05-25

Condition / research focus: Infertility
Sponsor: Southern Cross Fertility Centre
Countries with listed sites: India
Registry dates and results: Start: 2012-04. Completion: 2012-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cetrorelix (drug) — also listed as: Cetrotide
Luprolide Acetate (drug) — also listed as: Lupron

Where the study takes place — 3 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Sat Kaival Hospital Pvt. Ltd.
Anand, Gujarat, India
Site recruitment: Recruiting
Disha Fertility & Surgical Hospital
Indore, Madhya Pradesh, India
Site recruitment: Recruiting
Southern Cross Fertility Center
Mumbai, Maharashtra, India
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer

ClinicalTrials.gov · NCT00653757 · Registry updated: 2012-03-19

Condition / research focus: Prostate Cancer
Sponsor: Mayo Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2002-03. Completion: 2007-12 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

goserelin acetate (drug)
leuprolide acetate (drug)
image-guided radiation therapy (radiation)
intensity-modulated radiation therapy (radiation)

Where the study takes place — 1 listed sites

Mayo Clinic in Arizona
Scottsdale, Arizona, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer

ClinicalTrials.gov · NCT00426777 · Registry updated: 2012-02-03

Condition / research focus: Prostate Cancer
Sponsor: CMX Research
Countries with listed sites: Canada
Registry dates and results: Start: 2007-01. Completion: 2009-02 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

risedronate (drug) — also listed as: Actonel
risedronate (drug) — also listed as: Actonel
Control (drug)

Where the study takes place — 21 listed sites

Southern Interior Medical Research Corporation
Kelowna, British Columbia, Canada
Site recruitment: Not reported
Dr. Cal Andreou
Surrey, British Columbia, Canada
Site recruitment: Not reported
Dr. Allan Patrick
Fredericton, New Brunswick, Canada
Site recruitment: Not reported
The Male/Female Health and Research Centre
Barrie, Ontario, Canada
Site recruitment: Not reported
Dr. Stanley Flax
Brampton, Ontario, Canada
Site recruitment: Not reported
Brantford Urology Research, Medical Arts Building
Brantford, Ontario, Canada
Site recruitment: Not reported
G. Kenneth Jansz Medicine Professional Corporation
Burlington, Ontario, Canada
Site recruitment: Not reported
Urology Research Centre
Burlington, Ontario, Canada
Site recruitment: Not reported
Northern Urology Centre
Greater Sudbury, Ontario, Canada
Site recruitment: Not reported
Guelph Urology Associates
Guelph, Ontario, Canada
Site recruitment: Not reported
Credit Valley Medical Arts Centre
Mississauga, Ontario, Canada
Site recruitment: Not reported
Mor Urology Inc., Bayview Business Centre
Newmarket, Ontario, Canada
Site recruitment: Not reported
The Male and Female Health Centre
Oakville, Ontario, Canada
Site recruitment: Not reported
Orillia Urology Associates
Orillia, Ontario, Canada
Site recruitment: Not reported
Urotec
Oshawa, Ontario, Canada
Site recruitment: Not reported
Dr. Todd Webster
Owen Sound, Ontario, Canada
Site recruitment: Not reported
Kawartha Urology Associates
Peterborough, Ontario, Canada
Site recruitment: Not reported
Dr. Allan Abramovitch
Scarborough Village, Ontario, Canada
Site recruitment: Not reported
The Male Health Centre
Toronto, Ontario, Canada
Site recruitment: Not reported
Dr. Roger J. Buckley
Willowdale, Ontario, Canada
Site recruitment: Not reported
Urology South Shore Research
Greenfield Park, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2TerminatedINTERVENTIONAL

Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448

ClinicalTrials.gov · NCT01132404 · Registry updated: 2012-01-31

Condition / research focus: Prostate Cancer; Prostatic Neoplasms
Sponsor: Millennium Pharmaceuticals, Inc.
Countries with listed sites: France
Registry dates and results: Start: 2010-11. Completion: 2011-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprorelin (drug)
TAK-448 (drug)

Where the study takes place — 1 listed sites

Hôpital Edouard Herriot, 5, Place d'Arsonval, Pavillon V - Urologie et chirurgie de la transplantation
Lyon, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)

ClinicalTrials.gov · NCT00805935 · Registry updated: 2012-01-27

Condition / research focus: Polycystic Ovarian Syndrome; Infertility
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2009-01. Completion: 2010-09 (may be estimated). Results are posted in this registry.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Menotropin (drug) — also listed as: Menopur®
Progesterone vaginal insert (drug) — also listed as: Endometrin®
Follitropin beta (drug) — also listed as: Follistim Pen®
Progesterone in oil (drug)
leuprolide acetate (drug) — also listed as: Lupron

Where the study takes place — 6 listed sites

Conceptions Reproductive Associates of Colorado
Littleton, Colorado, United States
Site recruitment: Not reported
Women's Medical Research Group LLC, Florida
Clearwater, Florida, United States
Site recruitment: Not reported
Fertility Center of Illinois
Chicago, Illinois, United States
Site recruitment: Not reported
Weill Cornell Medical College
New York, New York, United States
Site recruitment: Not reported
Women & Infants' Hospital of RI
Providence, Rhode Island, United States
Site recruitment: Not reported
Center for Assisted Reproduction
Bedford, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

ClinicalTrials.gov · NCT00283062 · Registry updated: 2012-01-26

Condition / research focus: Prostatic Neoplasms
Sponsor: Sanofi
Countries with listed sites: Australia · Austria · Brazil · Canada · France · Germany · India · Israel · Italy · Mexico · Netherlands · Poland · Russia · South Africa · Turkey (Türkiye) · United Kingdom · United States
Registry dates and results: Start: 2005-12. Completion: 2010-12 (may be estimated). Results are posted in this registry.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Docetaxel (TAXOTERE®) Chemotherapy (drug)
Leuprolide acetate ( ELIGARD®) Hormonal Therapy (drug)
Docetaxel (TAXOTERE®) Chemotherapy (drug)
Leuprolide acetate ( ELIGARD®) Hormonal Therapy (drug)
Leuprolide acetate ( ELIGARD®) Hormonal Therapy (drug)

Where the study takes place — 17 listed sites

Sanofi-Aventis Administrative Office
Bridgewater, New Jersey, United States
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Macquarie Park, Australia
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Vienna, Austria
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
São Paulo, Brazil
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Québec, Canada
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Paris, France
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Frankfurt, Germany
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Mumbai, India
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Netanya, Israel
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Milan, Italy
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Col. Coyoacan, Mexico
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
PE Gouda, Netherlands
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Warsaw, Poland
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Moscow, Russia
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Gauteng, South Africa
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Guildford Surrey, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration

ClinicalTrials.gov · NCT01513954 · Registry updated: 2012-01-20

Condition / research focus: Infertility, Female
Sponsor: Red Rock Fertility Center
Countries with listed sites: United States
Registry dates and results: Start: 2012-01. Completion: 2013-06 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Red Rock Fertility Center
Las Vegas, Nevada, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)

ClinicalTrials.gov · NCT01078545 · Registry updated: 2012-01-16

Condition / research focus: Advanced Prostate Cancer; Lower Urinary Tract Symptoms
Sponsor: Abbott
Countries with listed sites: Poland · Ukraine
Registry dates and results: Start: 2008-09. Completion: 2010-11 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide acetate Depot Susp. 11.25 mg (Poland), 3.75 mg (Ukraine) (drug) — also listed as: Lupron Depot/Leuprolide acetate 11.25 mg, Lucrin Depot 11.25 mg, Lupron Depot/Leuprolide acetate 3.75 mg, Lucrin Depot 3.75 mg

Where the study takes place — 143 listed sites

Site Reference ID/Investigator# 31076
Bełchatów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31002
Bialystok, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30977
Bialystok, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31030
Bialystok, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31048
Bialystok, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31083
Bobrowniki, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31028
Bydgoszcz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31014
Bytom, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31006
Bytom, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31018
Bytom, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31007
Ciechanów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31004
Elblag, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31090
Elblag, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31044
Ełk, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30994
Florentynów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 9803
Gdansk, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31057
Gdansk, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31101
Gdansk, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31097
Gdansk, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30984
Gliwice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30976
Gmina Brwinów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31009
Gmina Poddębice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31051
Imielnik Stary, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31023
Inowrocław, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31074
Inowrocław, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31032
Jankowo, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31067
Jarosławiec, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30995
Jastków, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31065
Jastrzębie Zdrój, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31031
Jastrzębie Zdrój, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31054
Jelenia Góra, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30997
Katowice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31036
Katowice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31055
Kielce, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30999
Kielce, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31102
Kluczbork, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31068
Kolbudy, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31020
Konin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31019
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31087
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31050
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31025
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31043
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31011
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31061
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31053
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31029
Kurów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31012
Legnica, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31040
Leszno, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31082
Lidzbark Warmiński, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31086
Lodz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31052
Lodz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31047
Lodz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31089
Lodz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31060
Lodz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31049
Lublin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31100
Lublin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 33278
Lublin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31103
Lublin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31104
Lublin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30998
Lublin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31056
Michałowice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31001
Milcz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31085
Nysa, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30993
Oborniki Śląskie, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30974
Olsztyn, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31080
Olsztyn, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30989
Opole, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30978
Opole, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30982
Opole, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31033
Opole, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31075
Opole, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31042
Ostrów Wielkopolski, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31000
Piotrkow Trybunalski, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31069
Piła, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31045
Poznan, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31088
Poznan, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31021
Poznan, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31058
Poznan, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31034
Poznan, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30985
Poznan, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30979
Puszczykowo, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31005
Puławy, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31064
Puławy, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31022
Pyskowice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31013
Płock, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31016
Radlin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31099
Radom, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31041
Rzeszów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31024
Siedlce, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30988
Siemianowice Śląskie, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31063
Sieradz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31015
Sosnowiec, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30983
Starachowice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31084
Suwałki, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31092
Suwałki, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 33277
Suwałki, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31008
Swarzędz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30975
Szczecin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31046
Szczecin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30992
Szczecin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31035
Szczecin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31003
Świętochłowice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31079
Tarnowskie Góry, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31071
Tarnów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31091
Tarnów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30980
Tomaszów Mazowiecki, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31059
Torun, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30987
Turek, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31066
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31037
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31105
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31106
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31093
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31094
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31095
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31081
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31078
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30986
Wieliczka, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31027
Wroclaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31038
Wroclaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31062
Wroclaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31070
Wroclaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31077
Wroclaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31072
Wroclaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31098
Zabrze, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30996
Zamość, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31073
Złotniki, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30981
Żory, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31010
Łask, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31096
Łazy, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31039
Łomża, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31108
Dnipro, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31109
Dnipro, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31111
Donetsk, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31112
Kharkiv, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31113
Kharkiv, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31114
Kharkiv, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31209
Kiev, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31110
Kiev, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 21103
Kiev, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31107
Kiev, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31115
Simferopol, Ukraine
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer

ClinicalTrials.gov · NCT01487902 · Registry updated: 2011-12-08

Condition / research focus: Castration-resistant Prostate Cancer
Sponsor: Asan Medical Center
Countries with listed sites: South Korea
Registry dates and results: Start: 2010-07. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ADT (drug)
No ADT (drug)

Where the study takes place — 1 listed sites

Asan Medical Center
Seoul, South Korea
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

ClinicalTrials.gov · NCT00635817 · Registry updated: 2011-11-02

Condition / research focus: Puberty, Precocious
Sponsor: Abbott
Countries with listed sites: Puerto Rico · United States
Registry dates and results: Start: 2008-06. Completion: 2010-06 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide acetate 11.25 mg (drug) — also listed as: ABT-818, leuprolide acetate, Lupron
Leuprolide acetate 30 mg (drug) — also listed as: ABT-818, leuprolide acetate, Lupron

Where the study takes place — 25 listed sites

Site Reference ID/Investigator# 8765
Birmingham, Alabama, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 11522
Long Beach, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8756
Los Angeles, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8755
San Diego, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8761
San Diego, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8772
Stanford, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8749
Greenwood Village, Colorado, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8771
Gainesville, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8764
Jacksonville, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 17621
Pensacola, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8752
Indianapolis, Indiana, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8766
Shreveport, Louisiana, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8768
Minneapolis, Minnesota, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 17341
Saint Paul, Minnesota, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8759
Kansas City, Missouri, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8750
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8760
Tulsa, Oklahoma, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8763
Hershey, Pennsylvania, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8754
Salt Lake City, Utah, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8762
Seattle, Washington, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8753
Seattle, Washington, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 17922
Bayamón, Puerto Rico
Site recruitment: Not reported
Site Reference ID/Investigator# 17923
Ponce, Puerto Rico
Site recruitment: Not reported
Site Reference ID/Investigator# 18242
San Juan, Puerto Rico
Site recruitment: Not reported
Site Reference ID/Investigator# 19661
San Juan, Puerto Rico
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs

ClinicalTrials.gov · NCT01424618 · Registry updated: 2011-08-29

Condition / research focus: Implantation, Embryo
Sponsor: Kelly, Maureen, M.D.
Countries with listed sites: United States
Registry dates and results: Start: 2006-01. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide (drug) — also listed as: Lupron
Ganirelix (drug) — also listed as: Antagon

Where the study takes place — 1 listed sites

Society Hill Reproductive Medicine
Philadelphia, Pennsylvania, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of Leuprolide to Treat Prostate Cancer

ClinicalTrials.gov · NCT00626431 · Registry updated: 2011-07-19

Condition / research focus: Prostate Cancer
Sponsor: Abbott
Countries with listed sites: United States
Registry dates and results: Start: 2008-02. Completion: 2009-09 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide acetate - Formulation A (drug) — also listed as: Lupron, leuprorelin, gonadotropin hormone-releasing hormone (GnRH), luteinizing hormone-releasing hormone (LHRH)
Leuprolide acetate - Formulation B (drug) — also listed as: Lupron, leuprorelin, gonadotropin hormone-releasing hormone (GnRH), luteinizing hormone-releasing hormone (LHRH)

Where the study takes place — 63 listed sites

Site Reference ID/Investigator# 8696
Birmingham, Alabama, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8681
Homewood, Alabama, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8569
Anchorage, Alaska, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 9709
Phoenix, Arizona, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8662
Sierra Vista, Arizona, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8656
Tucson, Arizona, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 9705
Little Rock, Arkansas, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8691
Anaheim, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8566
Atherton, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8686
Fresno, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8698
Laguna Hills, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 9703
Long Beach, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8674
Los Angeles, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8650
Tarzana, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8699
Torrance, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8668
Denver, Colorado, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8646
Englewood, Colorado, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8652
Middlebury, Connecticut, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8697
New Britain, Connecticut, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8655
Aventura, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8648
Daytona Beach, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8660
New Smyrna Beach, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8658
Orange City, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8664
Orlando, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8651
Saint Augustine, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8661
St. Petersburg, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8568
Tallahassee, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8679
Wellington, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8562
West Palm Beach, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8670
Roswell, Georgia, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 9708
Thomasville, Georgia, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8693
Fort Wayne, Indiana, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8690
Newburgh, Indiana, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8565
Overland Park, Kansas, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8676
Greenbelt, Maryland, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8653
Las Vegas, Nevada, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8667
Lawrenceville, New Jersey, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8665
New York, New York, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8657
Poughkeepsie, New York, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 9702
The Bronx, New York, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8680
Charlotte, North Carolina, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8673
Concord, North Carolina, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8666
Raleigh, North Carolina, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8570
Salisbury, North Carolina, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8644
Winston-Salem, North Carolina, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8663
Cincinnati, Ohio, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8567
Columbus, Ohio, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8678
Bethany, Oklahoma, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8563
Bala-Cynwyd, Pennsylvania, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8692
Lancaster, Pennsylvania, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8689
Myrtle Beach, South Carolina, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8643
Germantown, Tennessee, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8695
Germantown, Tennessee, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8685
Memphis, Tennessee, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8564
Nashville, Tennessee, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8645
Nashville, Tennessee, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8641
Dallas, Texas, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8675
Houston, Texas, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8684
San Antonio, Texas, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8649
Tyler, Texas, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8683
Salt Lake City, Utah, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8672
Norfolk, Virginia, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8669
Richmond, Virginia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC

ClinicalTrials.gov · NCT00532272 · Registry updated: 2011-06-27

Condition / research focus: Metastatic Breast Cancer
Sponsor: National Cancer Center, Korea
Countries with listed sites: South Korea
Registry dates and results: Start: 2005-10. Completion: 2010-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole ,Goserelin (drug) — also listed as: Femara, Zoladex

Where the study takes place — 1 listed sites

National Cancer Center
Goyang, South Korea
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Study of Lupron Depot In The Treatment of Central Precocious Puberty

ClinicalTrials.gov · NCT00660010 · Registry updated: 2011-04-12

Condition / research focus: Puberty, Precocious
Sponsor: Abbott
Countries with listed sites: United States
Registry dates and results: Start: 1991-01. Completion: 2009-04 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Lupron (leuprolide acetate) (drug) — also listed as: Lupron

Where the study takes place — 9 listed sites

Site Reference ID/Investigator# 46673
Phoenix, Arizona, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 46671
San Francisco, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 14921
Stanford, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 14343
Aurora, Colorado, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 14341
St. Petersburg, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 14342
Indianapolis, Indiana, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 46672
Baltimore, Maryland, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 46668
Springfield, Massachusetts, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 14344
Hershey, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

ClinicalTrials.gov · NCT00002881 · Registry updated: 2010-11-09

Condition / research focus: Prostate Cancer
Sponsor: Eastern Cooperative Oncology Group
Countries with listed sites: United States
Registry dates and results: Start: 1996-10. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

flutamide (drug)
goserelin acetate (drug)
leuprolide acetate (drug)
suramin (drug)
therapeutic hydrocortisone (drug)
orchiectomy (procedure)

Where the study takes place — 1 listed sites

Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients

ClinicalTrials.gov · NCT00630799 · Registry updated: 2010-09-09

Condition / research focus: Prostate Cancer
Sponsor: GP-Pharm
Countries with listed sites: United States
Registry dates and results: Start: 2008-05. Completion: 2009-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

leuprolide acetate (drug)

Where the study takes place — 8 listed sites

Advanced Research Institute
New Port Richey, Florida, United States
Site recruitment: Not reported
Lawrenceville Urology
Lawrenceville, New Jersey, United States
Site recruitment: Not reported
Hudson Valley Urology
Poughkeepsie, New York, United States
Site recruitment: Not reported
Piedmont Medical Research
Winston-Salem, North Carolina, United States
Site recruitment: Not reported
Center for Urologic Care
Bryn Mawr, Pennsylvania, United States
Site recruitment: Not reported
Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
Site recruitment: Not reported
Urology Associates
Nashville, Tennessee, United States
Site recruitment: Not reported
Urology San Antonio Research, PA
San Antonio, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer

ClinicalTrials.gov · NCT00598312 · Registry updated: 2010-09-08

Condition / research focus: Prostate Cancer
Sponsor: Oakwood Laboratories, LLC
Countries with listed sites: United States
Registry dates and results: Start: 2007-04. Completion: 2008-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide Acetate for Injectable Suspension (drug)

Where the study takes place — 1 listed sites

Oakwood Laboratories, LLC
Oakwood Village, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

ClinicalTrials.gov · NCT00776074 · Registry updated: 2010-06-22

Condition / research focus: Uterine Fibroids
Sponsor: Takeda
Countries with listed sites: No country reported
Registry dates and results: Start: 2006-06. Completion: 2007-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprorelin (GF) (drug) — also listed as: Leuplin, Enantone, Trenantone, TAP-144SR
Leuprorelin (GC) (drug) — also listed as: Leuplin, Enantone, Trenantone, TAP-144SR

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation

ClinicalTrials.gov · NCT00275262 · Registry updated: 2010-05-06

Condition / research focus: Hodgkin Disease; Lymphoma, Non-Hodgkin; Multiple Myeloma; Mantle Cell Lymphoma
Sponsor: Abbott
Countries with listed sites: United States
Registry dates and results: Start: 2006-02. Completion: Not reported (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide acetate depot (LAD) 11.25 mg 3 Month (drug) — also listed as: Lupron
Matched placebo (drug)

Where the study takes place — 4 listed sites

Facility not reported
St Louis, Missouri, United States
Site recruitment: Not reported
Facility not reported
New York, New York, United States
Site recruitment: Not reported
Facility not reported
Durham, North Carolina, United States
Site recruitment: Not reported
Facility not reported
Houston, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Embryo Aneuploidies and Ovarian Stimulation

ClinicalTrials.gov · NCT00707525 · Registry updated: 2010-03-26

Condition / research focus: Embryo Aneuploidies
Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
Countries with listed sites: Spain
Registry dates and results: Start: 2008-02. Completion: 2010-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Preimplantation Genetic Diagnosis (procedure)

Where the study takes place — 1 listed sites

Instituto Valenciano de Infertilidad
Valencia, Valencia, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 22:07 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableUnknownINTERVENTIONAL

Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity

ClinicalTrials.gov · NCT01595334 · Registry updated: 2012-05-25

Condition / research focus: Infertility
Sponsor: Southern Cross Fertility Centre
Countries with listed sites: India
Registry dates and results: Start: 2012-04. Completion: 2012-11 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cetrorelix (drug) — also listed as: Cetrotide
Luprolide Acetate (drug) — also listed as: Lupron

Where the study takes place — 3 listed sites

Sat Kaival Hospital Pvt. Ltd.
Anand, Gujarat, India
Site recruitment: Recruiting
Disha Fertility & Surgical Hospital
Indore, Madhya Pradesh, India
Site recruitment: Recruiting
Southern Cross Fertility Center
Mumbai, Maharashtra, India
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer

ClinicalTrials.gov · NCT00653757 · Registry updated: 2012-03-19

Condition / research focus: Prostate Cancer
Sponsor: Mayo Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2002-03. Completion: 2007-12 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

goserelin acetate (drug)
leuprolide acetate (drug)
image-guided radiation therapy (radiation)
intensity-modulated radiation therapy (radiation)

Where the study takes place — 1 listed sites

Mayo Clinic in Arizona
Scottsdale, Arizona, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer

ClinicalTrials.gov · NCT00426777 · Registry updated: 2012-02-03

Condition / research focus: Prostate Cancer
Sponsor: CMX Research
Countries with listed sites: Canada
Registry dates and results: Start: 2007-01. Completion: 2009-02 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

risedronate (drug) — also listed as: Actonel
risedronate (drug) — also listed as: Actonel
Control (drug)

Where the study takes place — 21 listed sites

Southern Interior Medical Research Corporation
Kelowna, British Columbia, Canada
Site recruitment: Not reported
Dr. Cal Andreou
Surrey, British Columbia, Canada
Site recruitment: Not reported
Dr. Allan Patrick
Fredericton, New Brunswick, Canada
Site recruitment: Not reported
The Male/Female Health and Research Centre
Barrie, Ontario, Canada
Site recruitment: Not reported
Dr. Stanley Flax
Brampton, Ontario, Canada
Site recruitment: Not reported
Brantford Urology Research, Medical Arts Building
Brantford, Ontario, Canada
Site recruitment: Not reported
G. Kenneth Jansz Medicine Professional Corporation
Burlington, Ontario, Canada
Site recruitment: Not reported
Urology Research Centre
Burlington, Ontario, Canada
Site recruitment: Not reported
Northern Urology Centre
Greater Sudbury, Ontario, Canada
Site recruitment: Not reported
Guelph Urology Associates
Guelph, Ontario, Canada
Site recruitment: Not reported
Credit Valley Medical Arts Centre
Mississauga, Ontario, Canada
Site recruitment: Not reported
Mor Urology Inc., Bayview Business Centre
Newmarket, Ontario, Canada
Site recruitment: Not reported
The Male and Female Health Centre
Oakville, Ontario, Canada
Site recruitment: Not reported
Orillia Urology Associates
Orillia, Ontario, Canada
Site recruitment: Not reported
Urotec
Oshawa, Ontario, Canada
Site recruitment: Not reported
Dr. Todd Webster
Owen Sound, Ontario, Canada
Site recruitment: Not reported
Kawartha Urology Associates
Peterborough, Ontario, Canada
Site recruitment: Not reported
Dr. Allan Abramovitch
Scarborough Village, Ontario, Canada
Site recruitment: Not reported
The Male Health Centre
Toronto, Ontario, Canada
Site recruitment: Not reported
Dr. Roger J. Buckley
Willowdale, Ontario, Canada
Site recruitment: Not reported
Urology South Shore Research
Greenfield Park, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2TerminatedINTERVENTIONAL

Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448

ClinicalTrials.gov · NCT01132404 · Registry updated: 2012-01-31

Condition / research focus: Prostate Cancer; Prostatic Neoplasms
Sponsor: Millennium Pharmaceuticals, Inc.
Countries with listed sites: France
Registry dates and results: Start: 2010-11. Completion: 2011-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprorelin (drug)
TAK-448 (drug)

Where the study takes place — 1 listed sites

Hôpital Edouard Herriot, 5, Place d'Arsonval, Pavillon V - Urologie et chirurgie de la transplantation
Lyon, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)

ClinicalTrials.gov · NCT00805935 · Registry updated: 2012-01-27

Condition / research focus: Polycystic Ovarian Syndrome; Infertility
Sponsor: Ferring Pharmaceuticals
Countries with listed sites: United States
Registry dates and results: Start: 2009-01. Completion: 2010-09 (may be estimated). Results are posted in this registry.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Menotropin (drug) — also listed as: Menopur®
Progesterone vaginal insert (drug) — also listed as: Endometrin®
Follitropin beta (drug) — also listed as: Follistim Pen®
Progesterone in oil (drug)
leuprolide acetate (drug) — also listed as: Lupron

Where the study takes place — 6 listed sites

Conceptions Reproductive Associates of Colorado
Littleton, Colorado, United States
Site recruitment: Not reported
Women's Medical Research Group LLC, Florida
Clearwater, Florida, United States
Site recruitment: Not reported
Fertility Center of Illinois
Chicago, Illinois, United States
Site recruitment: Not reported
Weill Cornell Medical College
New York, New York, United States
Site recruitment: Not reported
Women & Infants' Hospital of RI
Providence, Rhode Island, United States
Site recruitment: Not reported
Center for Assisted Reproduction
Bedford, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

ClinicalTrials.gov · NCT00283062 · Registry updated: 2012-01-26

Condition / research focus: Prostatic Neoplasms
Sponsor: Sanofi
Countries with listed sites: Australia · Austria · Brazil · Canada · France · Germany · India · Israel · Italy · Mexico · Netherlands · Poland · Russia · South Africa · Turkey (Türkiye) · United Kingdom · United States
Registry dates and results: Start: 2005-12. Completion: 2010-12 (may be estimated). Results are posted in this registry.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Docetaxel (TAXOTERE®) Chemotherapy (drug)
Leuprolide acetate ( ELIGARD®) Hormonal Therapy (drug)
Docetaxel (TAXOTERE®) Chemotherapy (drug)
Leuprolide acetate ( ELIGARD®) Hormonal Therapy (drug)
Leuprolide acetate ( ELIGARD®) Hormonal Therapy (drug)

Where the study takes place — 17 listed sites

Sanofi-Aventis Administrative Office
Bridgewater, New Jersey, United States
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Macquarie Park, Australia
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Vienna, Austria
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
São Paulo, Brazil
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Québec, Canada
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Paris, France
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Frankfurt, Germany
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Mumbai, India
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Netanya, Israel
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Milan, Italy
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Col. Coyoacan, Mexico
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
PE Gouda, Netherlands
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Warsaw, Poland
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Moscow, Russia
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Gauteng, South Africa
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported
Sanofi-Aventis Administrative Office
Guildford Surrey, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Examination of Serum Progesterone Levels in an IVF Population Following Two Types of Egg Aspiration

ClinicalTrials.gov · NCT01513954 · Registry updated: 2012-01-20

Condition / research focus: Infertility, Female
Sponsor: Red Rock Fertility Center
Countries with listed sites: United States
Registry dates and results: Start: 2012-01. Completion: 2013-06 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Red Rock Fertility Center
Las Vegas, Nevada, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)

ClinicalTrials.gov · NCT01078545 · Registry updated: 2012-01-16

Condition / research focus: Advanced Prostate Cancer; Lower Urinary Tract Symptoms
Sponsor: Abbott
Countries with listed sites: Poland · Ukraine
Registry dates and results: Start: 2008-09. Completion: 2010-11 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide acetate Depot Susp. 11.25 mg (Poland), 3.75 mg (Ukraine) (drug) — also listed as: Lupron Depot/Leuprolide acetate 11.25 mg, Lucrin Depot 11.25 mg, Lupron Depot/Leuprolide acetate 3.75 mg, Lucrin Depot 3.75 mg

Where the study takes place — 143 listed sites

Site Reference ID/Investigator# 31076
Bełchatów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31002
Bialystok, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30977
Bialystok, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31030
Bialystok, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31048
Bialystok, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31083
Bobrowniki, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31028
Bydgoszcz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31014
Bytom, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31006
Bytom, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31018
Bytom, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31007
Ciechanów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31004
Elblag, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31090
Elblag, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31044
Ełk, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30994
Florentynów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 9803
Gdansk, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31057
Gdansk, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31101
Gdansk, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31097
Gdansk, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30984
Gliwice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30976
Gmina Brwinów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31009
Gmina Poddębice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31051
Imielnik Stary, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31023
Inowrocław, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31074
Inowrocław, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31032
Jankowo, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31067
Jarosławiec, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30995
Jastków, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31065
Jastrzębie Zdrój, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31031
Jastrzębie Zdrój, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31054
Jelenia Góra, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30997
Katowice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31036
Katowice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31055
Kielce, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30999
Kielce, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31102
Kluczbork, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31068
Kolbudy, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31020
Konin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31019
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31087
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31050
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31025
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31043
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31011
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31061
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31053
Krakow, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31029
Kurów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31012
Legnica, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31040
Leszno, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31082
Lidzbark Warmiński, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31086
Lodz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31052
Lodz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31047
Lodz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31089
Lodz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31060
Lodz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31049
Lublin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31100
Lublin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 33278
Lublin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31103
Lublin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31104
Lublin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30998
Lublin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31056
Michałowice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31001
Milcz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31085
Nysa, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30993
Oborniki Śląskie, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30974
Olsztyn, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31080
Olsztyn, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30989
Opole, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30978
Opole, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30982
Opole, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31033
Opole, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31075
Opole, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31042
Ostrów Wielkopolski, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31000
Piotrkow Trybunalski, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31069
Piła, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31045
Poznan, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31088
Poznan, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31021
Poznan, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31058
Poznan, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31034
Poznan, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30985
Poznan, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30979
Puszczykowo, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31005
Puławy, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31064
Puławy, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31022
Pyskowice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31013
Płock, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31016
Radlin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31099
Radom, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31041
Rzeszów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31024
Siedlce, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30988
Siemianowice Śląskie, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31063
Sieradz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31015
Sosnowiec, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30983
Starachowice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31084
Suwałki, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31092
Suwałki, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 33277
Suwałki, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31008
Swarzędz, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30975
Szczecin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31046
Szczecin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30992
Szczecin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31035
Szczecin, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31003
Świętochłowice, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31079
Tarnowskie Góry, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31071
Tarnów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31091
Tarnów, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30980
Tomaszów Mazowiecki, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31059
Torun, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30987
Turek, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31066
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31037
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31105
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31106
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31093
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31094
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31095
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31081
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31078
Warsaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30986
Wieliczka, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31027
Wroclaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31038
Wroclaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31062
Wroclaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31070
Wroclaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31077
Wroclaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31072
Wroclaw, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31098
Zabrze, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30996
Zamość, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31073
Złotniki, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 30981
Żory, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31010
Łask, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31096
Łazy, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31039
Łomża, Poland
Site recruitment: Not reported
Site Reference ID/Investigator# 31108
Dnipro, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31109
Dnipro, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31111
Donetsk, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31112
Kharkiv, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31113
Kharkiv, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31114
Kharkiv, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31209
Kiev, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31110
Kiev, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 21103
Kiev, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31107
Kiev, Ukraine
Site recruitment: Not reported
Site Reference ID/Investigator# 31115
Simferopol, Ukraine
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer

ClinicalTrials.gov · NCT01487902 · Registry updated: 2011-12-08

Condition / research focus: Castration-resistant Prostate Cancer
Sponsor: Asan Medical Center
Countries with listed sites: South Korea
Registry dates and results: Start: 2010-07. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ADT (drug)
No ADT (drug)

Where the study takes place — 1 listed sites

Asan Medical Center
Seoul, South Korea
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

ClinicalTrials.gov · NCT00635817 · Registry updated: 2011-11-02

Condition / research focus: Puberty, Precocious
Sponsor: Abbott
Countries with listed sites: Puerto Rico · United States
Registry dates and results: Start: 2008-06. Completion: 2010-06 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide acetate 11.25 mg (drug) — also listed as: ABT-818, leuprolide acetate, Lupron
Leuprolide acetate 30 mg (drug) — also listed as: ABT-818, leuprolide acetate, Lupron

Where the study takes place — 25 listed sites

Site Reference ID/Investigator# 8765
Birmingham, Alabama, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 11522
Long Beach, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8756
Los Angeles, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8755
San Diego, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8761
San Diego, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8772
Stanford, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8749
Greenwood Village, Colorado, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8771
Gainesville, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8764
Jacksonville, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 17621
Pensacola, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8752
Indianapolis, Indiana, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8766
Shreveport, Louisiana, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8768
Minneapolis, Minnesota, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 17341
Saint Paul, Minnesota, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8759
Kansas City, Missouri, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8750
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8760
Tulsa, Oklahoma, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8763
Hershey, Pennsylvania, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8754
Salt Lake City, Utah, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8762
Seattle, Washington, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8753
Seattle, Washington, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 17922
Bayamón, Puerto Rico
Site recruitment: Not reported
Site Reference ID/Investigator# 17923
Ponce, Puerto Rico
Site recruitment: Not reported
Site Reference ID/Investigator# 18242
San Juan, Puerto Rico
Site recruitment: Not reported
Site Reference ID/Investigator# 19661
San Juan, Puerto Rico
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs

ClinicalTrials.gov · NCT01424618 · Registry updated: 2011-08-29

Condition / research focus: Implantation, Embryo
Sponsor: Kelly, Maureen, M.D.
Countries with listed sites: United States
Registry dates and results: Start: 2006-01. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide (drug) — also listed as: Lupron
Ganirelix (drug) — also listed as: Antagon

Where the study takes place — 1 listed sites

Society Hill Reproductive Medicine
Philadelphia, Pennsylvania, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of Leuprolide to Treat Prostate Cancer

ClinicalTrials.gov · NCT00626431 · Registry updated: 2011-07-19

Condition / research focus: Prostate Cancer
Sponsor: Abbott
Countries with listed sites: United States
Registry dates and results: Start: 2008-02. Completion: 2009-09 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide acetate - Formulation A (drug) — also listed as: Lupron, leuprorelin, gonadotropin hormone-releasing hormone (GnRH), luteinizing hormone-releasing hormone (LHRH)
Leuprolide acetate - Formulation B (drug) — also listed as: Lupron, leuprorelin, gonadotropin hormone-releasing hormone (GnRH), luteinizing hormone-releasing hormone (LHRH)

Where the study takes place — 63 listed sites

Site Reference ID/Investigator# 8696
Birmingham, Alabama, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8681
Homewood, Alabama, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8569
Anchorage, Alaska, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 9709
Phoenix, Arizona, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8662
Sierra Vista, Arizona, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8656
Tucson, Arizona, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 9705
Little Rock, Arkansas, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8691
Anaheim, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8566
Atherton, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8686
Fresno, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8698
Laguna Hills, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 9703
Long Beach, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8674
Los Angeles, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8650
Tarzana, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8699
Torrance, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8668
Denver, Colorado, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8646
Englewood, Colorado, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8652
Middlebury, Connecticut, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8697
New Britain, Connecticut, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8655
Aventura, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8648
Daytona Beach, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8660
New Smyrna Beach, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8658
Orange City, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8664
Orlando, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8651
Saint Augustine, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8661
St. Petersburg, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8568
Tallahassee, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8679
Wellington, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8562
West Palm Beach, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8670
Roswell, Georgia, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 9708
Thomasville, Georgia, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8693
Fort Wayne, Indiana, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8690
Newburgh, Indiana, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8565
Overland Park, Kansas, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8676
Greenbelt, Maryland, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8653
Las Vegas, Nevada, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8667
Lawrenceville, New Jersey, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8665
New York, New York, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8657
Poughkeepsie, New York, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 9702
The Bronx, New York, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8680
Charlotte, North Carolina, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8673
Concord, North Carolina, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8666
Raleigh, North Carolina, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8570
Salisbury, North Carolina, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8644
Winston-Salem, North Carolina, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8663
Cincinnati, Ohio, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8567
Columbus, Ohio, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8678
Bethany, Oklahoma, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8563
Bala-Cynwyd, Pennsylvania, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8692
Lancaster, Pennsylvania, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8689
Myrtle Beach, South Carolina, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8643
Germantown, Tennessee, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8695
Germantown, Tennessee, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8685
Memphis, Tennessee, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8564
Nashville, Tennessee, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8645
Nashville, Tennessee, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8641
Dallas, Texas, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8675
Houston, Texas, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8684
San Antonio, Texas, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8649
Tyler, Texas, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8683
Salt Lake City, Utah, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8672
Norfolk, Virginia, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 8669
Richmond, Virginia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Goserelin/Letrozole in Premenopausal Patients vs Letrozole Alone in Postmenopausal Patients With MBC

ClinicalTrials.gov · NCT00532272 · Registry updated: 2011-06-27

Condition / research focus: Metastatic Breast Cancer
Sponsor: National Cancer Center, Korea
Countries with listed sites: South Korea
Registry dates and results: Start: 2005-10. Completion: 2010-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole ,Goserelin (drug) — also listed as: Femara, Zoladex

Where the study takes place — 1 listed sites

National Cancer Center
Goyang, South Korea
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Study of Lupron Depot In The Treatment of Central Precocious Puberty

ClinicalTrials.gov · NCT00660010 · Registry updated: 2011-04-12

Condition / research focus: Puberty, Precocious
Sponsor: Abbott
Countries with listed sites: United States
Registry dates and results: Start: 1991-01. Completion: 2009-04 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Lupron (leuprolide acetate) (drug) — also listed as: Lupron

Where the study takes place — 9 listed sites

Site Reference ID/Investigator# 46673
Phoenix, Arizona, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 46671
San Francisco, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 14921
Stanford, California, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 14343
Aurora, Colorado, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 14341
St. Petersburg, Florida, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 14342
Indianapolis, Indiana, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 46672
Baltimore, Maryland, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 46668
Springfield, Massachusetts, United States
Site recruitment: Not reported
Site Reference ID/Investigator# 14344
Hershey, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

ClinicalTrials.gov · NCT00002881 · Registry updated: 2010-11-09

Condition / research focus: Prostate Cancer
Sponsor: Eastern Cooperative Oncology Group
Countries with listed sites: United States
Registry dates and results: Start: 1996-10. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

flutamide (drug)
goserelin acetate (drug)
leuprolide acetate (drug)
suramin (drug)
therapeutic hydrocortisone (drug)
orchiectomy (procedure)

Where the study takes place — 1 listed sites

Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients

ClinicalTrials.gov · NCT00630799 · Registry updated: 2010-09-09

Condition / research focus: Prostate Cancer
Sponsor: GP-Pharm
Countries with listed sites: United States
Registry dates and results: Start: 2008-05. Completion: 2009-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

leuprolide acetate (drug)

Where the study takes place — 8 listed sites

Advanced Research Institute
New Port Richey, Florida, United States
Site recruitment: Not reported
Lawrenceville Urology
Lawrenceville, New Jersey, United States
Site recruitment: Not reported
Hudson Valley Urology
Poughkeepsie, New York, United States
Site recruitment: Not reported
Piedmont Medical Research
Winston-Salem, North Carolina, United States
Site recruitment: Not reported
Center for Urologic Care
Bryn Mawr, Pennsylvania, United States
Site recruitment: Not reported
Carolina Urologic Research Center
Myrtle Beach, South Carolina, United States
Site recruitment: Not reported
Urology Associates
Nashville, Tennessee, United States
Site recruitment: Not reported
Urology San Antonio Research, PA
San Antonio, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer

ClinicalTrials.gov · NCT00598312 · Registry updated: 2010-09-08

Condition / research focus: Prostate Cancer
Sponsor: Oakwood Laboratories, LLC
Countries with listed sites: United States
Registry dates and results: Start: 2007-04. Completion: 2008-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide Acetate for Injectable Suspension (drug)

Where the study takes place — 1 listed sites

Oakwood Laboratories, LLC
Oakwood Village, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

ClinicalTrials.gov · NCT00776074 · Registry updated: 2010-06-22

Condition / research focus: Uterine Fibroids
Sponsor: Takeda
Countries with listed sites: No country reported
Registry dates and results: Start: 2006-06. Completion: 2007-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprorelin (GF) (drug) — also listed as: Leuplin, Enantone, Trenantone, TAP-144SR
Leuprorelin (GC) (drug) — also listed as: Leuplin, Enantone, Trenantone, TAP-144SR

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation

ClinicalTrials.gov · NCT00275262 · Registry updated: 2010-05-06

Condition / research focus: Hodgkin Disease; Lymphoma, Non-Hodgkin; Multiple Myeloma; Mantle Cell Lymphoma
Sponsor: Abbott
Countries with listed sites: United States
Registry dates and results: Start: 2006-02. Completion: Not reported (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Leuprolide acetate depot (LAD) 11.25 mg 3 Month (drug) — also listed as: Lupron
Matched placebo (drug)

Where the study takes place — 4 listed sites

Facility not reported
St Louis, Missouri, United States
Site recruitment: Not reported
Facility not reported
New York, New York, United States
Site recruitment: Not reported
Facility not reported
Durham, North Carolina, United States
Site recruitment: Not reported
Facility not reported
Houston, Texas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Embryo Aneuploidies and Ovarian Stimulation

ClinicalTrials.gov · NCT00707525 · Registry updated: 2010-03-26

Condition / research focus: Embryo Aneuploidies
Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
Countries with listed sites: Spain
Registry dates and results: Start: 2008-02. Completion: 2010-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Preimplantation Genetic Diagnosis (procedure)

Where the study takes place — 1 listed sites

Instituto Valenciano de Infertilidad
Valencia, Valencia, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →